Defining How Oncogenic and Developmental Mutations of PIK3R1 Alter the Regulation of Class IA Phosphoinositide 3-Kinases
Authors:
- 1 February 2020
- Vol. 28 (2) , 145-156.e5
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Michael Smith Health Research BC (17686)
- Canadian Institutes of Health Research
- Cancer Research Society (CRS-24368)
This publication has 61 references indexed in Scilit:
- Mutations in PIK3R1 Cause SHORT SyndromeThe American Journal of Human Genetics, 2013
- Dynamic steps in receptor tyrosine kinase mediated activation of class IA phosphoinositide 3-kinases (PI3K) captured by H/D exchange (HDX-MS)Advances in Biological Regulation, 2013
- Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CANature Genetics, 2012
- De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromesNature Genetics, 2012
- Dynamics of the Phosphoinositide 3-Kinase p110δ Interaction with p85α and Membranes Reveals Aspects of Regulation Distinct from p110αStructure, 2011
- Structure of Lipid Kinase p110β/p85β Elucidates an Unusual SH2-Domain-Mediated Inhibitory MechanismMolecular Cell, 2011
- Regulation of Class IA PI 3-kinases: C2 domain-iSH2 domain contacts inhibit p85/p110α and are disrupted in oncogenic p85 mutantsProceedings of the National Academy of Sciences, 2009
- Somatic Mutations in p85α Promote Tumorigenesis through Class IA PI3K ActivationCancer Cell, 2009
- A frequent kinase domain mutation that changes the interaction between PI3Kα and the membraneProceedings of the National Academy of Sciences, 2009
- SH2 domains recognize specific phosphopeptide sequencesCell, 1993